Wen Yu

Wen Yu is a Principal Scientist at AstraZeneca, with a distinguished background in computational biology and extensive experience in early phase clinical trials, particularly in inflammation and oncology. Prior roles include Principal Scientist at Amgen, where expertise in pharmacodynamic and patient stratification biomarkers was developed. Wen Yu has also contributed as a Senior Scientist at Amgen, leading the creation of a qualitative platform for automated proteomic analysis, and held positions at Diversa Inc. and Pfizer, focusing on protein and mRNA expression analysis and glycopeptide profiling. Educational credentials include a Master's degree in Chemistry from the University of Houston.